AKT1 and type 2 diabetes mellitus: Surfactin was thought to prevent T2DM by, first, reversing pancreatic dysfunctions through reducing oxidative stress, ERS and inflammatory responses, and second, improving insulin resistance by regulating the PI3K/AKT signaling pathway.